These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21248634)

  • 1. Noninvasive tools to assess liver disease.
    Clark PJ; Patel K
    Curr Opin Gastroenterol; 2011 May; 27(3):210-6. PubMed ID: 21248634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive tools to assess liver disease.
    Patel K
    Curr Opin Gastroenterol; 2010 May; 26(3):227-33. PubMed ID: 20179592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2006 Jul; 101(7):1497-9. PubMed ID: 16863552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of liver fibrosis.
    Adams LA
    J Gastroenterol Hepatol; 2011 May; 26(5):802-9. PubMed ID: 21198831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive markers of fibrosis for longitudinal assessment of fibrosis in chronic liver disease: are they ready for prime time?
    Thuluvath PJ; Krok KL
    Am J Gastroenterol; 2005 Sep; 100(9):1981-3. PubMed ID: 16128942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing liver fibrosis.
    Castera L
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of liver fibrosis.
    Martínez SM; Crespo G; Navasa M; Forns X
    Hepatology; 2011 Jan; 53(1):325-35. PubMed ID: 21254180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
    Moreno S; García-Samaniego J; Moreno A; Ortega E; Pineda JA; del Romero J; Tural C; von Wichmann MA; Berenguer J; Castro A; Espacio R
    J Viral Hepat; 2009 Apr; 16(4):249-58. PubMed ID: 19215579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining non-invasive methods for assessment of liver fibrosis.
    Bourlière M; Pénaranda G; Adhoute X; Oules V; Castellani P
    Gastroenterol Clin Biol; 2008 Sep; 32(6 Suppl 1):73-9. PubMed ID: 18973849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.
    Pinzani M; Vizzutti F; Arena U; Marra F
    Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):95-106. PubMed ID: 18253138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive assessment of chronic liver and gastric diseases.
    Plebani M; Basso D
    Clin Chim Acta; 2007 May; 381(1):39-49. PubMed ID: 17374528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?
    Castera L; Bedossa P
    Liver Int; 2011 Jan; 31 Suppl 1():13-7. PubMed ID: 21205132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers.
    Friedrich-Rust M; Müller C; Winckler A; Kriener S; Herrmann E; Holtmeier J; Poynard T; Vogl TJ; Zeuzem S; Hammerstingl R; Sarrazin C
    J Clin Gastroenterol; 2010 Jan; 44(1):58-65. PubMed ID: 19581812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.
    Kim SU; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1472-3. PubMed ID: 20796140
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma fibronectin in chronic liver disease--marker of fibrosis?].
    Simon K; Zalewska M; Gładysz A; Rotter K; Piszko P; Głowacki A
    Przegl Lek; 1995; 52(4):129-32. PubMed ID: 7638358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver biopsy versus noninvasive methods--fibroscan and fibrotest in the diagnosis of non-alcoholic fatty liver disease: a review of the literature.
    Pais R; Lupşor M; Poantă L; Silaghi A; Rusu ML; Badea R; Dumitraşcu DL
    Rom J Intern Med; 2009; 47(4):331-40. PubMed ID: 21179914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.